Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 5 | 1 | — | — | 8 |
Ovarian epithelial carcinoma | D000077216 | — | — | 2 | 4 | 1 | — | — | 7 |
Hypersensitivity | D006967 | HP_0012393 | T78.40 | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 3 | 1 | — | — | — | 3 |
Fallopian tube neoplasms | D005185 | — | — | — | 2 | — | — | — | 2 |
Adenocarcinoma | D000230 | — | — | — | 2 | — | — | — | 2 |
Peritoneal neoplasms | D010534 | — | — | — | 1 | — | — | — | 1 |
Adenocarcinoma of lung | D000077192 | — | — | — | 1 | — | — | — | 1 |
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Pituitary neoplasms | D010911 | — | — | — | 1 | — | — | — | 1 |
Adenoma | D000236 | — | — | — | 1 | — | — | — | 1 |
Pituitary diseases | D010900 | — | E23.7 | — | 1 | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Farletuzumab |
INN | farletuzumab |
Description | Farletuzumab (humanized mab) |
Classification | Antibody |
Drug class | monoclonal antibodies |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL1743016 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 2O09BG0OWA (ChemIDplus, GSRS) |